biotech · Recurrent Pericarditis · Acute Myocarditis · CRDL
Cardiol Therapeutics
Cardiol Therapeutics is a biotech organization headquartered in Toronto, CA. It trades on NYSE under ticker CRDL. Primary therapeutic focus areas include Recurrent Pericarditis, Acute Myocarditis, Spontaneous Coronary Ar
2265 Upper Middle Rd E, Suite 602, Greater Toronto Area, Ontario L6H 0G5, CA HQ
2017 Founded
27 Employees
Public company Type
CRDL · NYSE Ticker
Company details
- Status
- Public
- HQ
- 2265 Upper Middle Rd E, Suite 602, Greater Toronto Area, Ontario L6H 0G5, CA
- Founded
- 2017
- Employees
- 27
- Programs
- 11
- Drugs
- 31
- Patents
- 15
BA-SCAD
Approved · small molecule · Spontaneous Coronary Artery Dissection.
BA-SCAD for Spontaneous Coronary Artery Dissection. is a Approved program (small_molecule) at Cardiol Therapeutics with 1 ClinicalTrials.gov record(s).
Internal code BA-SCAD
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Cardiol Therapeutics
- Phase
- Approved
- Modality
- small_molecule
- Indication
- Spontaneous Coronary Artery Dissection.
- Status
- active
- Trials
- 1